Description
An atypical antipsychotic; binds to dopamine D1, D2, and D4 receptors (Kis = 31, 11, and 27 nM, respectively) as well as 5-HT2A, 5-HT2C, and 5-HT3 receptors (Kis = 4, 11, and 57 nM, respectively); binds to M1 muscarinic acetylcholine, α1-adrenergic, and histamine H1 receptors (Kis = 2, 19, and 7 nM, respectively); decreases immobility time in the forced swim test in non-stressed and prenatally-stressed rats at 0.5 mg/kg; decreases the number of avoidances made in the conditioned avoidance response test in rats at 0.5 and 1 mg/kg ,
Formal name: 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine
Synonyms: LY170053
Molecular weight: 312.4
CAS: 132539-06-1
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Ion Channel Modulation||Product Type|Biochemicals|Receptor Pharmacology||Research Area|Neuroscience|Behavioral Neuroscience|Bipolar Disorder||Research Area|Neuroscience|Behavioral Neuroscience|Depression||Research Area|Neuroscience|Behavioral Neuroscience|Schizophrenia & Psychosis